CompletedEarly Phase 1

Studying of Natural Constituents' Treatment of Plantar Warts

Egypt20 participantsStarted 2022-10-20

Plain-language summary

Moringa banana nigella and Banna coat extract were prepared and formulated in the form of bi gel for transdermal delivery of these plant extracts. The formulation was prepared and charterized for organoleptic charters, morphology, and penetration efficacy. The optimised formulation was assessed clinically on patients suffering from plantar warts. The clinical study was phase 1 and interventional randomised allocation.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female patient aged 18 years or more. * Clinical evaluation * Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm Exclusion Criteria: * Patient suspected to be immunocompromised * Patient aged under 18 years * Patient refusing to sign the consent * Pregnant or lactating women

What they're measuring

Complete clinical remission of the warts

Timeframe: 30 days

Clinical assessment of warts curement

Timeframe: 30 days

Trial details

NCT IDNCT05592041

SponsorDeraya University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-18

View on ClinicalTrials.gov More Plantar Wart trials